Therefore, although studies on AQP-4 are insufficient, patients with early CKD may develop glymphatic system dysfunction due to decreased AQP-4 expression, which plays an important factor in the glymphatic pathway. This evidence concerns the gene AQP4 and chronic kidney disease.